Skip to main content
OpenTrials

Clinical trial condition

B-cell Malignancies

Explore clinical trials studying B-cell Malignancies. Study availability and eligibility vary by location and protocol.

18 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

B-cell Malignancies trial results

Completed

A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)

NCT02327078

Conditions
Adnexal Diseases, Astrocytoma, B-cell Malignancies, +53 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • USC Norris Cancer Center Los Angeles, California, United States
  • UCSF - University of California San Francisco San Francisco, California, United States
View all 24 locations
View Trial Details
Completed

Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies

NCT04551963

Conditions
B-cell Malignancies
Locations
  • Concord Repatriation General Hospital Concord, New South Wales, Australia
  • John Flynn Private Hospital Tugun, Queensland, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • Flinders Medical Centre Bedford PK, South Australia, Australia
View Trial Details
Completed

A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib in Subjects With Previously Treated B-Cell Malignancies (CITADEL-101)

NCT02018861

Conditions
B-cell Malignancies
Locations
  • University of Alabama At Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of Michigan Cancer Center Ann Arbor, Michigan, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Nyu Langone Laura and Isaac Perlmutter Cancer Center New York, United States
View Trial Details
Completed

Study of the Safety and Pharmacokinetics of BGB-3111 in Subjects With B-Cell Lymphoid Malignancies

NCT02343120

Conditions
B-cell Malignancies
Locations
  • Banner MD Anderson Cancer Centre Gilbert, Arizona, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • M.D. Anderson Cancer Center Houston, Texas, United States
View all 23 locations
View Trial Details
Completed

A Clinical Study Using MEDI-551 in Adult Participants With Relapsed or Refractory Advanced B-Cell Malignancies

NCT00983619

Conditions
B-cell Malignancies, Cancer, Neoplasms
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site La Jolla, California, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Tampa, Florida, United States
View all 21 locations
View Trial Details
Completed

Combination Study of Urelumab and Rituximab in Patients With B-cell Non-Hodgkins Lymphoma

NCT01775631

Conditions
B-cell Malignancies
Locations
  • Ucla Department Of Medicine Los Angeles, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • University Of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
View all 15 locations
View Trial Details

Related conditions